Omega Bio-Tek
Private Company
Total funding raised: $20M
Overview
Omega Bio-tek is a established, privately-held provider of nucleic acid purification technologies, operating in the diagnostics and life science research tools sector. The company has built a strong reputation over 25 years for product reliability and customer partnership, with its kits being utilized by prominent institutions like the University of Oxford and diagnostic labs such as Myriad Genetics and Gravity Diagnostics. Its business model centers on selling consumable kits and providing custom automation services, positioning it as a key enabler in genomics workflows without developing its own therapeutic or diagnostic tests. The company appears to be revenue-generating, supported by a diverse customer base and a portfolio focused on extraction efficiency and workflow integration.
Technology Platform
Magnetic bead-based nucleic acid (DNA/RNA) purification chemistry and custom automated workflow integration services for liquid handling platforms.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Omega Bio-tek competes in the crowded nucleic acid purification market against dominant multinational corporations (Qiagen, Thermo Fisher, Promega) and numerous smaller specialists. It differentiates through a strong focus on customer partnership, customization for automated workflows, and high-touch technical support, rather than competing solely on breadth of catalog or lowest price.